These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 23577205)

  • 21. Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies.
    Kaverin NV; Rudneva IA; Govorkova EA; Timofeeva TA; Shilov AA; Kochergin-Nikitsky KS; Krylov PS; Webster RG
    J Virol; 2007 Dec; 81(23):12911-7. PubMed ID: 17881439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and structural characterization of a broadly neutralizing antibody targeting a novel conserved epitope on the influenza virus H5N1 hemagglutinin.
    Du L; Jin L; Zhao G; Sun S; Li J; Yu H; Li Y; Zheng BJ; Liddington RC; Zhou Y; Jiang S
    J Virol; 2013 Feb; 87(4):2215-25. PubMed ID: 23221567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoclonal antibodies targeting the synthetic peptide corresponding to the polybasic cleavage site on H5N1 influenza hemagglutinin.
    Tsai HJ; Chi LA; Yu AL
    J Biomed Sci; 2012 Apr; 19(1):37. PubMed ID: 22471562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Replication-Defective Influenza Virus Harboring H5 and H7 Hemagglutinins Provides Protection against H5N1 and H7N9 Infection in Mice.
    Tian X; Landreth S; Lu Y; Pandey K; Zhou Y
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33177192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epitope mapping of neutralizing monoclonal antibody in avian influenza A H5N1 virus hemagglutinin.
    Ohkura T; Kikuchi Y; Kono N; Itamura S; Komase K; Momose F; Morikawa Y
    Biochem Biophys Res Commun; 2012 Feb; 418(1):38-43. PubMed ID: 22226969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishment of the cross-clade antigen detection system for H5 subtype influenza viruses using peptide monoclonal antibodies specific for influenza virus H5 hemagglutinin.
    Takahashi H; Nagata S; Odagiri T; Kageyama T
    Biochem Biophys Res Commun; 2018 Apr; 498(4):758-763. PubMed ID: 29524417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative efficacy of neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian H5N1 influenza virus.
    Wei CJ; Xu L; Kong WP; Shi W; Canis K; Stevens J; Yang ZY; Dell A; Haslam SM; Wilson IA; Nabel GJ
    J Virol; 2008 Jul; 82(13):6200-8. PubMed ID: 18417563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation and characterisation of monoclonal antibodies against influenza virus A, subtype H5N1.
    Linke S; Neubauer K; Dorner MB; Dorner BG; Pauli G; Schweiger B
    J Virol Methods; 2011 Jul; 175(1):85-94. PubMed ID: 21549148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel humanized antibody neutralizes H5N1 influenza virus via two different mechanisms.
    Tan Y; Ng Q; Jia Q; Kwang J; He F
    J Virol; 2015 Apr; 89(7):3712-22. PubMed ID: 25609802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural and functional definition of a vulnerable site on the hemagglutinin of highly pathogenic avian influenza A virus H5N1.
    Wang P; Zuo Y; Sun J; Zuo T; Zhang S; Guo S; Shi X; Liang M; Zhou P; Zhang L; Wang X
    J Biol Chem; 2019 Mar; 294(12):4290-4303. PubMed ID: 30737282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human single-chain antibodies that neutralize homologous and heterologous strains and clades of influenza A virus subtype H5N1.
    Maneewatch S; Thanongsaksrikul J; Songserm T; Thueng-In K; Kulkeaw K; Thathaisong U; Srimanote P; Tongtawe P; Tapchaisri P; Chaicumpa W
    Antivir Ther; 2009; 14(2):221-30. PubMed ID: 19430097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conserved synthetic peptides from the hemagglutinin of influenza viruses induce broad humoral and T-cell responses in a pig model.
    Vergara-Alert J; Argilaguet JM; Busquets N; Ballester M; Martín-Valls GE; Rivas R; López-Soria S; Solanes D; Majó N; Segalés J; Veljkovic V; Rodríguez F; Darji A
    PLoS One; 2012; 7(7):e40524. PubMed ID: 22815759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The epitope and neutralization mechanism of AVFluIgG01, a broad-reactive human monoclonal antibody against H5N1 influenza virus.
    Cao Z; Meng J; Li X; Wu R; Huang Y; He Y
    PLoS One; 2012; 7(5):e38126. PubMed ID: 22662275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unmasking Stem-Specific Neutralizing Epitopes by Abolishing N-Linked Glycosylation Sites of Influenza Virus Hemagglutinin Proteins for Vaccine Design.
    Liu WC; Jan JT; Huang YJ; Chen TH; Wu SC
    J Virol; 2016 Oct; 90(19):8496-508. PubMed ID: 27440889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal antibodies against the fusion peptide of hemagglutinin protect mice from lethal influenza A virus H5N1 infection.
    Prabhu N; Prabakaran M; Ho HT; Velumani S; Qiang J; Goutama M; Kwang J
    J Virol; 2009 Mar; 83(6):2553-62. PubMed ID: 19109379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serologic cross-reactivity among humans and birds infected with highly pathogenic avian influenza A subtype H5N1 viruses in China.
    Li Z; Ma C; Liu Z; He W
    Immunol Lett; 2011 Mar; 135(1-2):59-63. PubMed ID: 20923686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An antibody against a novel and conserved epitope in the hemagglutinin 1 subunit neutralizes numerous H5N1 influenza viruses.
    Oh HL; Akerström S; Shen S; Bereczky S; Karlberg H; Klingström J; Lal SK; Mirazimi A; Tan YJ
    J Virol; 2010 Aug; 84(16):8275-86. PubMed ID: 20519402
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The antigenic architecture of the hemagglutinin of influenza H5N1 viruses.
    Velkov T; Ong C; Baker MA; Kim H; Li J; Nation RL; Huang JX; Cooper MA; Rockman S
    Mol Immunol; 2013 Dec; 56(4):705-19. PubMed ID: 23933511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insertion of Basic Amino Acids in the Hemagglutinin Cleavage Site of H4N2 Avian Influenza Virus (AIV)-Reduced Virus Fitness in Chickens is Restored by Reassortment with Highly Pathogenic H5N1 AIV.
    Gischke M; Ulrich R; I Fatola O; Scheibner D; Salaheldin AH; Crossley B; Böttcher-Friebertshäuser E; Veits J; Mettenleiter TC; Abdelwhab EM
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32231159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice.
    Wang Y; Wu J; Xue C; Wu Z; Lin Y; Wei Y; Wei X; Qin J; Zhang Y; Wen Z; Chen L; Liu GD; Cao Y
    Antiviral Res; 2017 Jul; 143():97-105. PubMed ID: 28408133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.